Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (61-70 of 372) with videos related to

Pageof 38
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancerG Larry Maxwell, G V R Chandramouli, Lou Dainty, et al.
Molecular Cancer Therapeutics|January 16, 2015
Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78Lihong Mo, Robin E Bachelder, Margaret Kennedy, et al.
American Journal of Obstetrics and Gynecology|September 2, 2014
MicroRNAs in endometrial cancers from black and white patientsG Larry Maxwell, Yutaka Shoji, Kathleen Darcy, et al.
Gynecologic Oncology|March 23, 2006
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study, Angeles Alvarez Secord, Paula S Lee, et al.
Gynecologic Oncology|February 6, 2007
Regulation of the metastasis suppressor gene MKK4 in ovarian cancerMonique A Spillman, Judith Lacy, Susan K Murphy, et al.
Genome Research|December 16, 2010
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancerNoriomi Matsumura, Zhiqing Huang, Seiichi Mori, et al.
American Journal of Obstetrics and Gynecology|December 31, 2011
Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cellsGustavo C Rodriguez, Jane M Turbov, Andrew Berchuck, et al.
American Journal of Epidemiology|February 28, 2008
Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal womenPatricia G Moorman, Brian Calingaert, Rachel T Palmieri, et al.
Gynecologic Oncology|October 22, 2008
Relationship between tamoxifen use and high risk endometrial cancer histologic typesAmy E Bland, Brian Calingaert, Angeles Alvarez Secord, et al.
Scientific Reports|December 4, 2023
Periostin facilitates ovarian cancer recurrence by enhancing cancer stemnessZhiqing Huang, Olivia Byrd, Sarah Tan, et al.
Pageof 38

Showing results (61-70 of 372) with videos related to

Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancerG Larry Maxwell, G V R Chandramouli, Lou Dainty, et al.
Molecular Cancer Therapeutics|January 16, 2015
Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78Lihong Mo, Robin E Bachelder, Margaret Kennedy, et al.
American Journal of Obstetrics and Gynecology|September 2, 2014
MicroRNAs in endometrial cancers from black and white patientsG Larry Maxwell, Yutaka Shoji, Kathleen Darcy, et al.
Gynecologic Oncology|March 23, 2006
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study, Angeles Alvarez Secord, Paula S Lee, et al.
Gynecologic Oncology|February 6, 2007
Regulation of the metastasis suppressor gene MKK4 in ovarian cancerMonique A Spillman, Judith Lacy, Susan K Murphy, et al.
Genome Research|December 16, 2010
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancerNoriomi Matsumura, Zhiqing Huang, Seiichi Mori, et al.
American Journal of Obstetrics and Gynecology|December 31, 2011
Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cellsGustavo C Rodriguez, Jane M Turbov, Andrew Berchuck, et al.
American Journal of Epidemiology|February 28, 2008
Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal womenPatricia G Moorman, Brian Calingaert, Rachel T Palmieri, et al.
Gynecologic Oncology|October 22, 2008
Relationship between tamoxifen use and high risk endometrial cancer histologic typesAmy E Bland, Brian Calingaert, Angeles Alvarez Secord, et al.
Scientific Reports|December 4, 2023
Periostin facilitates ovarian cancer recurrence by enhancing cancer stemnessZhiqing Huang, Olivia Byrd, Sarah Tan, et al.
Pageof 38